🔗 Permalink

Assignee profile:

Forerunner Pharma Research Co., Ltd.

City:

Tokyo

Country:

Japan

Published Applications:

Last publication date:

2012-11-08

Patent Grants:

Last grant date:

2015-07-14

Top Inventors for applications by Forerunner Pharma Research Co., Ltd.

These are the the leading inventors for applications assigned to Forerunner Pharma Research Co., Ltd.:

Hiroyuki ABURATANI 6 Tokyo, Japan
Shinichi FUNAHASHI 3 Tokyo, Japan
Shigeto Kawai 3 Tokyo, Japan
Naoki Kimura 3 Tokyo, Japan

Shunpei Ishikawa 3 Tokyo, Japan
Kiyotaka NAKANO 3 Tokyo, Japan
Hirotaka Ito 3 Tokyo, Japan
Kenji Yoshida 2 Tokyo, Japan

Yuichi Torisu 1 Tokyo, Japan
Yuriko UEHARA 1 Tokyo, Japan
Kiyataka Nakano 1 Tokyo, Japan
Kenji YOSHIDA 1 Toyko, Japan

Recent patent applications by Forerunner Pharma Research Co., Ltd.

Forerunner Pharma Research Co., Ltd. based in Tokyo, JP has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2012-11-08

US20120282173A1

Chemistry; metallurgy

PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT

#2 | 2012-06-07

US20120141501A1

Chemistry; metallurgy

Pharmaceutical Composition Containing Antagonist of EGF Family Ligand as Component

#3 | 2012-05-24 ✅ Patent 9,079,957 granted on 2015-07-14

US20120128678A1

Chemistry; metallurgy

Diagnosis and treatment of cancer using anti-TMPRSS11E antibody

#4 | 2012-01-19

US20120014870A1

Chemistry; metallurgy

Diagnosis and Treatment of Cancer Using Anti-LGR7 Antibody

#5 | 2012-01-05 ✅ Patent 9,139,647 granted on 2015-09-22

US20120004117A1

Chemistry; metallurgy

Diagnosis and treatment of cancer using anti-TM4SF20 antibody

#6 | 2011-07-21 ✅ Patent 8,680,243 granted on 2014-03-25

US20110176995A1

Chemistry; metallurgy

Diagnosis and treatment of cancer using anti-GPR49 antibody

#7 | 2010-10-21 ✅ Patent 8,975,374 granted on 2015-03-10

US20100266502A1

Chemistry; metallurgy

Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient

#8 | 2010-09-23 ✅ Patent 8,546,546 granted on 2013-10-01

US20100240872A1

Physics

Anti-Muc 17 antibody

#9 | 2010-05-06

US20100111852A1

Chemistry; metallurgy

Anti-Claudin 3 Monoclonal Antibody and Treatment and Diagnosis of Cancer Using the Same

#10 | 2010-05-06

US20100111851A1

Physics

DIAGNOSIS AND TREATMENT OF CANCER BY USING ANTI-PRG-3 ANTIBODY

#11 | 2010-04-15

US20100092457A1

Chemistry; metallurgy

Diagnosis and Treatment of Cancer Using Anti-Desmoglein-3 Antibodies

#12 | 2010-02-18 ✅ Patent 8,192,740 granted on 2012-06-05

US20100041074A1

Chemistry; metallurgy

Pharmaceutical composition comprising anti-GRP78 antibody as active ingredient

#13 | 2010-02-11 ✅ Patent 8,946,385 granted on 2015-02-03

US20100035280A1

Physics

Chimeric Fcγ receptor and method for determination of ADCC activity by using the receptor

#14 | 2009-12-31 ✅ Patent 9,017,684 granted on 2015-04-28

US20090324491A1

Physics

Diagnosis and treatment of cancer using anti-EREG antibody

AssigneeID:

173540 ⎘